Equity futures edged slightly lower Monday as investors await the January jobs report and inflation data, as well as earnings reports, following a volatile week that included a tech-led selloff and a brief Bitcoin plunge. Markets had bounced Friday after earlier losses, with the Dow hitting a milestone amid the sector volatility.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
In pre-market trading, S&P 500 futures fell 0.04%, Nasdaq 100 futures fell 0.1% and Dow futures fell 0.06%.
Check out this morning’s top movers from around Wall Street, compiled by The Fly.
HIGHER –
- Eli Lilly (LLY) up 2% after agreeing to buy Oma Therapeutics for $2.4B in cash
- Kroger (KR) up 7% after naming former Walmart US (WMT) head Greg Foran as its new CEO
- SoFi Technologies (SOFI) up 2% after Citizens upgraded the stock to Outperform from Market Perform
- Tegna (TGNA) up 9% after President Donald Trump vocalized support for Nexstar’s (NXST) proposed $3.5B acquisition of the company
UP AFTER EARNINGS –
DOWN AFTER EARNINGS –
LOWER –
- Hims & Hers (HIMS) down 22% after company pulls copycat weight-loss pill, Novo Nordisk (NVO) sues
- Li Auto (LI) down 3% after JPMorgan downgraded the stock to Underweight from Neutral
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Novo Nordisk sues Hims & Hers over Wegovy pill, injection copycats, CNBC reports
- Hims & Hers price target lowered to $21 from $26 at BofA
- HIMS Stock Drops, NVO Jumps after Hims & Hers Halts Selling $49 Wegovy Copy
- Hims & Hers (HIMS) Shares Sink 16% as FDA Crackdown Halts Wegovy Copycat Pill
- The Week That Was, The Week Ahead: Macro and Markets, Feb. 8
